Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status

Keywords

GefitinibLung cancerMedicineOncologyInternal medicineCancerEpidermal growth factor receptor

Affiliated Institutions

Related Publications

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

Elizabeth Buck , Alexandra Eyzaguirre , Sharon Barr +7 more

Abstract Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is frequently observed in human carcinomas. Inhibitors of EGFR signaling have show...

2007 Molecular Cancer Therapeutics 186 citations

Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

Sharon Barr , Stuart Thomson , Elizabeth Buck +10 more

Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin. As carcinomas progress, these tumors may lose epithelial morphology and acquire mes...

2008 Clinical & Experimental Metastasis 199 citations

A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Gerlinde Pilkington , Angela Boland , Tamara Brown +3 more

Our aim was to evaluate the clinical effectiveness of chemotherapy treatments currently licensed in Europe and recommended by the National Institute for Health and Care Excellen...

2015 Thorax 116 citations

Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: Results by performance status, EGFR mutation, histology and response to previous induction

Pui San Tan , Gilberto Lopes , Sanchalika Acharyya +2 more

Maintenance treatments show clinically meaningful survival benefits in good performance status patients with advanced NSCLC not progressing after first-line chemotherapy. Benefi...

2015 European Journal of Cancer 17 citations

A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>

Philipp Sievers , Martin Sill , Daniel Schrimpf +29 more

Abstract Background Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epiderma...

2020 Neuro-Oncology 112 citations

Publication Info

Year: 2004
Type: article
Volume: 23
Issue: 1
Pages: 73-77
Citations: 41
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Gee‐Chen Chang, 
                                
                                    Kun‐Chieh Chen, 
                                
                                    Tsung‐Ying Yang
                                
                                et al.
                            
                            (2004). 
                            Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status. 
                            Investigational New Drugs
                            , 23
                            (1)
                            , 73-77.
                            https://doi.org/10.1023/b:drug.0000047108.39129.7c
                        

Identifiers

DOI: 10.1023/b:drug.0000047108.39129.7c